McKnight’s reports that, “The push for long-term care facilities to abandon the use of off-label use of antipsychotic medications for residents with dementia will intensify over the next two years, Centers for Medicare & Medicaid Services officials said.”
“The National Partnership to Improve Dementia Care is pushing forward with a 25% reduction of the medications by the end of 2015, which it wants to hit 30% by the end of next year, according to CMS coordinator Michelle Laughman, speaking during a CMS Open Door Forum call. Nursing homes reached the national goal of a 15.1% reduction in 2013.”
LTC will face more pressure to lessen antipsychotics, government officials say (McKnight’s, June 25, 2015)
